Related Experiment Video
Updated: May 27, 2026
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Regulatory dendritic cells in the tumor immunoenvironment
Galina V Shurin1, Camille E Ouellette2, Michael R Shurin2
1Division of Experimental Pathology, Department of Pathology and Immunology, University of Pittsburgh Medical Center, 3550 Terrace Street, Scaife Hall S733, Pittsburgh, PA, 15261, USA. shuringv@upmc.edu.
Cancer Immunology, Immunotherapy : CII
|November 9, 2011
Summary
Tumor cells induce regulatory dendritic cells (regDCs) that suppress anti-tumor immunity. Targeting these regDCs offers a potential therapeutic strategy for enhancing anti-cancer responses.
Area of Science:
- Immunology
- Cancer Biology
- Tumor Microenvironment
Background:
- The tumor microenvironment significantly influences cancer progression through complex cellular interactions.
- Immune cell infiltration into tumors plays a dual role, impacting both tumor growth and patient outcomes.
- Regulatory dendritic cells (regDCs) are emerging as key players in tumor progression by suppressing anti-tumor immunity.
Purpose of the Study:
- To investigate the role of tumor-derived factors in the induction of regulatory dendritic cells (regDCs).
- To characterize the function and phenotype of tumor-induced regDCs.
- To explore the therapeutic potential of targeting regDCs in cancer immunotherapy.
Main Methods:
- In vitro and in vivo studies using various tumor cell lines.
- Analysis of soluble factors produced by tumor cells.
- Phenotypic and functional characterization of conventional DCs and induced regDCs.
- Assessment of T cell proliferation suppression by regDCs.
Main Results:
- Tumor cell lines secrete soluble factors that induce the polarization of conventional DCs into regDCs.
- Induced regDCs exhibit distinct phenotypes and functions compared to conventional DCs.
- These regDCs effectively suppress the proliferation of pre-activated T cells.
- regDCs were observed both in vitro and in vivo.
Conclusions:
- Tumor-derived factors actively shape the immune response by generating suppressive regDCs.
- Understanding regDC biology provides a novel therapeutic target for cancer treatment.
- Repolarizing protumorigenic regDCs into pro-immunogenic cells could enhance anti-tumor immunity.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...